APA (7th ed.) Citation

Lee, M., Son, M. J., Hong, S., Ryu, J., Min, J., Lee, D., . . . Kim, G. (2024). Discovery of a selective cytochrome P450 4A inhibitor for the treatment of metabolic dysfunction‐associated fatty liver disease. Clinical & Translational Medicine, 14(10), 1. https://doi.org/10.1002/ctm2.1816

Chicago Style (17th ed.) Citation

Lee, Minji, et al. "Discovery of a Selective Cytochrome P450 4A Inhibitor for the Treatment of Metabolic Dysfunction‐associated Fatty Liver Disease." Clinical & Translational Medicine 14, no. 10 (2024): 1. https://doi.org/10.1002/ctm2.1816.

MLA (9th ed.) Citation

Lee, Minji, et al. "Discovery of a Selective Cytochrome P450 4A Inhibitor for the Treatment of Metabolic Dysfunction‐associated Fatty Liver Disease." Clinical & Translational Medicine, vol. 14, no. 10, 2024, p. 1, https://doi.org/10.1002/ctm2.1816.